Kelly E Rowe, MD

Professional Memberships

American College of Physicians

Infectious Disease Society of America

Selected Publications

Rowe K, Theodore DA, Zucker J, Cohensedgh O, LaSota E, Carnevale C, Cohall A, Olender S, Gordon P, Sobieszczyk ME. Lost2PrEP: Understanding Reasons for Pre-Exposure Prophylaxis and Sexual Health Care Disengagement Among Men Who Have Sex with Men Attending a Sexual Health Clinic at a Large Urban Academic Medical Center in New York City. AIDS Patient Care STDS. 2022 Apr;36(4):153-158. doi: 10.1089/apc.2022.0004. PMID: 35438522; PMCID: PMC9057871."

Hodde M, Rowe KE, Surapaneni K, Terrigno P, Brighenti A, Altschuler EL. Management of Severe Hemiballismus: Treatment Challenges in the Acute Inpatient Rehabilitation Setting: A Case Presentation. PM R. 2017 Jul;9(7):732-735. doi: 10.1016/j.pmrj.2016.10.023. Epub 2016 Nov 10. PMID: 27840300."

Schank JR, Pickens CL, Rowe KE, Cheng K, Thorsell A, Rice KC, Shaham Y, Heilig M. Stress-induced reinstatement of alcohol-seeking in rats is selectively suppressed by the neurokinin 1 (NK1) antagonist L822429. Psychopharmacology (Berl). 2011 Nov;218(1):111-9. doi: 10.1007/s00213-011-2201-z. Epub 2011 Feb 22. PMID: 21340476; PMCID: PMC3192232."

Schank JR, Goldstein AL, Rowe KE, King CE, Marusich JA, Wiley JL, Carroll FI, Thorsell A, Heilig M. The kappa opioid receptor antagonist JDTic attenuates alcohol seeking and withdrawal anxiety. Addict Biol. 2012 May;17(3):634-47. doi: 10.1111/j.1369-1600.2012.00455.x. PMID: 22515275; PMCID: PMC3334348."

Schank JR, Nelson BS, Damadzic R, Tapocik JD, Yao M, King CE, Rowe KE, Cheng K, Rice KC, Heilig M. Neurokinin-1 receptor antagonism attenuates neuronal activity triggered by stress-induced reinstatement of alcohol seeking. Neuropharmacology. 2015 Dec;99:106-14. doi: 10.1016/j.neuropharm.2015.07.009. Epub 2015 Jul 15. PMID: 26188146; PMCID: PMC4655129.